longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Artelo Biosciences(ARTL.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·05/18/2026 20:05
US
GOSS
-9.89%
US
LTRN
+0.32%
US
AIM
-2.41%
benzinga_article·05/18/2026 20:05
US
GOSS
-9.89%
US
LTRN
+0.32%
US
AIM
-2.41%

Artelo Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results.

benzinga_article·05/15/2026 23:16
US
ARTL
-5.28%
US
BBH
+0.32%
US
IBB
-0.01%
benzinga_article·05/15/2026 23:16
US
ARTL
-5.28%
US
BBH
+0.32%
US
IBB
-0.01%

Artelo Biosciences | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/15/2026 04:17
US
ARTL
-5.28%
Earnings Watch·05/15/2026 04:17
US
ARTL
-5.28%

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development | ARTL Stock News

StockTitan·04/28/2026 12:25
US
ARTL
-5.28%
US
LABU
-0.39%
StockTitan·04/28/2026 12:25
US
ARTL
-5.28%
US
LABU
-0.39%

What's Behind The Rise In Artelo Biosciences Stock?

Fidelity·04/21/2026 00:06
US
ARTL
-5.28%
US
IBB
-0.01%
US
BBH
+0.32%
Fidelity·04/21/2026 00:06
US
ARTL
-5.28%
US
IBB
-0.01%
US
BBH
+0.32%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Artelo Biosciences released FY2026 Q1 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -4.0027 (forecast USD -0.78)
03:00
Feb25
Artelo Biosciences released FY2025 earnings on February 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -37.5481 (forecast USD -36.33)
04:00
Artelo Biosciences released FY2025 Q4 earnings on February 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -6.181 (forecast USD -4.71)
04:00
Nov13
Artelo Biosciences released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -41.7408
04:00
Artelo Biosciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.97 (forecast USD -0.82)
04:00
Sep9
Nasdaq-listed Artelo Biosciences Completes $3 Million Rights Offering
08:22

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -2.958 M, EPS -4.0027

Mar10
Reverse Stock Split(EST)

1-for-3 Reverse Stock Split

Feb24
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -4.166 M, EPS -6.181

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATPC
3.830
+83.25%
+1.750
AKAN
26.315
+81.36%
+11.805
NIVF
1.200
+62.35%
+0.442
CODX
3.770
+57.74%
+1.370
PCLA
2.112
+50.85%
+0.712
QBTX
18.005
+50.80%
+6.065
RGTX
27.020
+49.45%
+8.940
RGTU
27.290
+49.21%
+9.000
NCPL
0.6606
+45.54%
+0.206
AMPGR
0.8100
+44.64%
+0.250
View More